Document is current
Any future updates will be listed below
-
Authors
Ehm, Franz https://orcid.org/0000-0003-3749-4000
Tesch, Falko https://orcid.org/0000-0001-8933-643X
Menzer, Simone
Loser, Friedrich
Bechmann, Lars
Vivirito, Annika
Wende, Danny https://orcid.org/0000-0002-0545-0807
Batram, Manuel https://orcid.org/0000-0003-4445-965X
Buschmann, Tilo
Ludwig, Marion https://orcid.org/0000-0002-2446-0090
Roessler, Martin https://orcid.org/0000-0002-4662-4156
Seifert, Martin
Sarganas Margolis, Giselle https://orcid.org/0000-0002-6296-3174
Reitzle, Lukas https://orcid.org/0000-0001-7095-6567
Koenig, Christina
Schulte, Claudia
Ballesteros, Pedro
Bassler, Stefan
Bitterer, Thomas
Riederer, Cordula
Berner, Reinhard https://orcid.org/0000-0002-6216-9173
Scheidt-Nave, Christa https://orcid.org/0000-0002-1902-7567
Schmitt, Jochen https://orcid.org/0000-0003-0264-0960
Toepfner, Nicole https://orcid.org/0000-0002-9693-4419
-
Funding
Funding for this research was provided by:
Bundesministerium für Gesundheit (2521NIK705, 2521NIK705, 2521NIK705, 2521NIK705, 2521NIK705, 2521NIK705, 2521NIK705, 2521NIK705, 2521NIK705)
Technische Universität Dresden
- License Information
-
More Information
Article History
Received: 5 April 2024
Accepted: 9 September 2024
First Online: 16 September 2024
Declarations
:
: FT, FE, AV, ML, MS, GSM, LR, CSN, and JS and received institutional funding for this project from the German Federal Ministry of Health (BMG, grant no. 2521NIK705). Unrelated to this study, JS reports institutional grants for investigator-initiated research from the German Federal Joint Committee, German Ministry of Health, German Ministry of Research, European Union, German Federal State of Saxony, Novartis, Sanofi, ALK, and Pfizer. He participated in advisory board meetings as a paid consultant for Sanofi, Lilly, and ALK. JS serves the German Ministry of Health as a member of the German National Council for Health and Care. RB is a board member of the German Society for Pediatrics (DGKJ), deputy president of the Saxonian and Thuringian Society for Pediatrics (STGKJM), coop. board member of the German Society for Pediatric Infectious Diseases (DGPI), member of the Expert Advisory Board on Pandemic Affaires of the German Government), member of the Expert Advisory Board of the German Robert Koch-Institut on Pandemic Respiratory Tract Infections, member of the German National Vaccine Board (STIKO) at the German Robert Koch-Institut, and member of the German Federal Commission on Pharmacotherapy and Medical Devices in Children and Adolescents (KAKJ) at the German Federal Institute for Drugs and Medical Devices (BfArM). NT is vice president of the German Society for Pediatric Infectious Diseases (DGPI) and is the DGPI-mandated person for the pediatric expert group on long-COVID in children and adolescents. NT serves as treasurer of the Network Young Infection Medicine (jUNITE). She received payments for lectures with the German DGKJ, BVKJ, DGPI and other invited teaching sessions at German faculties. NT reports honoraria for manuscripts published in Monatsschrift Kinderheilkunde, Kinder- und Jugendarzt, and Doctors today. MB reports payment for data analysis which is presented in this paper from DAK-Gesundheit. Unrelated to this study, MB reports grants or contracts from GSK, Janssen, Sanofi, Viatris, MSD, Moderna, and Pfizer. MB participated in advisory board meetings as a paid consultant for GSK, Janssen, and Sanofi. MB received further consulting fees and grants from German Federal Joint Committee and selected German sickness funds. The other authors have nothing to disclose.
